This NMN Study Failed — Then 4 People Rewrote It Before You Saw It

The researchers found their supplement didn't work. Then they wrote a conclusion saying it did. And that was just Stage Zero. By the time this study reached your phone, it had passed through four more sets of hands — each one making the same edit. This video traces one real NMN clinical trial (published May 2024, 60 older adults, 12 weeks, randomised double-blind placebo-controlled) from the results section of the paper to a Fortune Magazine buying guide. What you'll see: → The primary outcome that failed → The conclusion that contradicted it → The press release that escalated it → The health site that rewrote it → The trusted publication that laundered it And at the end: a 2-minute skill you can use on every health claim you encounter. Nobody in this chain lied. That's what makes it worth understanding. Check out my website: https://peakvitalityblueprint.com/ 🔔 If this changed how you read health headlines, subscribe. 📄 REFERENCED SOURCES Study: Morifuji, M., Higashi, S., Ebihara, S. et al. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. GeroScience 46, 4671–4688 (2024). https://doi.org/10.1007/s11357-024-01204-1 Press Release: https://www.meiji.com/global/news/2024/pdf/240621_01.pdf NMN.com Article: https://www.nmn.com/news/nmn-prevents-physical-decline-and-poor-sleep-latest-clinical-trial Fortune Article: https://fortune.com/article/best-nmn-supplements/ #longevity #healthspan #nmn #supplementindustry #scienceliteracy #evidencebasedmedicine #criticalthinking #langlebigkeit #nmnsupplement #wissenschaftskommunikation